Top

Published in:

01-01-2013 | Original Article

A disease severity scoring system for children with type 1 Gaucher disease

Authors: Staci Kallish, Paige Kaplan

Published in: European Journal of Pediatrics | Issue 1/2013

Abstract

Almost half of patients with Gaucher disease are diagnosed by the age of 10 years, and approximately two thirds are diagnosed by the age of 20 years. Besides symptomatic children, some presymptomatic children are being diagnosed through community screening programs and because of affected siblings. In addition, it is anticipated that in the near future, newborn screening for lysosomal diseases such as Gaucher disease will be introduced in the USA, identifying additional pre/nonsymptomatic children. Currently, there is no severity scoring system for children. A validated disease severity scoring system in the pediatric Gaucher population will be essential for classifying disease severity in these children, monitoring their disease progression, making decisions about when to treat them, and monitoring disease improvement with therapy. A severity scoring system will also be helpful in comparing therapeutic options as new therapies are designed. Therefore, a Pediatric Gaucher Severity Scoring System (PGS3) was devised using expert opinion and validated in 26 patients with type 1 Gaucher disease. The PGS3 correlates well with disease severity in patients at diagnosis and over time. Conclusion: A practical system that will help clinical management, based on signs and symptoms in children with type 1 Gaucher disease, is presented.

Brady RO, Kanfer JN, Shapiro D (1965) Metabolism of glucocerebrosides, II: evidence of an enzymatic deficiency in Gaucher disease. Biochem Biophys Res Commun 18:221–225PubMedCrossRef

Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A (2000) The Gaucher registry—demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Int Med 160:2835–2843CrossRef

Di Rocco M, Giona F, Carubbi F, Linari S, Minichilli F, Brady RO, Mariani G, Cappellini MD (2008) A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease. Haematologica 93:1211–1218PubMedCrossRef

Elstein D, Gellman A, Altarescu G, Abrahamov A, Hadas-Halpern I, Phillips M, Margalit M, Lebel E, Itzchaki M, Zimran A (2010) Disease severity in sibling pairs with type 1 Gaucher disease. J Inherit Metab Dis 33:79–83PubMedCrossRef

Grabowski GA, Kolodny EH, Weinreb NJ, Rosenbloom BE, Prakash-Cheng A, Kaplan P, Charrow J, Pastores GM, Mistry PK (2012) Gaucher disease: phenotypic and genetic variation, Chapter 146.1. Online Mendelian Inheritance in Man. At www.ncbi.nlm.nih.gov/Omim. Accessed May 2011

Grabowski GA, Andria G, Baldellou A, Campbell PE, Charrow J, Cohen IJ, Harris CM, Kaplan P, Mendel E, Pocovi M, Vellodi A (2004) Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis, and assessment. Consensus statements. Eur J Pediatr 163:58–66PubMedCrossRef

Kaplan P, Andersson HC, Kacena KA, Yee JD (2006) The clinical and demographic characteristics of nonneuropathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 160:603–608PubMedCrossRef

Kaplan P, Baris H, De Meirleir L, Di Rocco M, El-Beshlawy A, Huemer M, Martins AM,. Nascu I, Rohrbach M, Steinbach L, Cohen IJ (2012) Revised recommendations for the management of Gaucher disease in children. Eur J Pediatr (in press)

Kaplan P, Mazur A, Manor O, Charrow J, Esplin J, Gribble TJ, Wappner RS, Wisch JS, Weinreb NJ (1996) Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase. J Pediatr 129:149–153PubMedCrossRef

10.

Kauli R, Zaizov R, Lazar L, Pertzelan A, Laron Z, Galatzer A, Phillip M, Yaniv Y, Cohen IJ (2000) Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy. IMAJ 2:158–163PubMed

11.

Maas M, Hangartner T, Mariani G, McHugh K, Moore S, Grabowski GA, Kaplan P, Vellodi A, Yee J, Steinbach L (2008) Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease. Skeletal Radiol 37:185–188PubMedCrossRef

12.

Maas M, van Kuijk C, Stoker J, Hollak CEM, Akkerman EM, Aerts JFMG, den Heeten GJ (2003) Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging—initial experience. Radiol 229:554–561CrossRef

13.

Mistry PK, Liu J, Yang M, Nottoli T, McGrath J, Jain D, Zhang K, Keutzer J, Chuang WL, Mehal WZ, Zhao H, Lin A, Mane S, Liu X, Peng YZ, Li JH, Agrawal M, Zhu LL, Blair HC, Robinson LJ, Iqbal J, Sun L, Zaidi M (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. PNAS 107:19473–19478PubMedCrossRef

14.

Mistry PK, Weinreb NJ, Kaplan P, Cole JA, Gwosdow AR, Hangartner T (2011) Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents, and adults. Blood Cells Mol Dis 46:66–72PubMedCrossRef

15.

Weinreb NJ, Cappellini MD, Cox TM, Giannini EH, Grabowski GA, Hwu WL, Mankin H, Martins AM, Sawyer C, vom Dahl S, Yeh MS, Zimran A (2010) A validated disease severity scoring system for adults with type 1 Gaucher disease. Genet Med 12(1):44–51PubMedCrossRef

16.

Zevin S, Abrahamov A, Hadas-Halpern A, Kannai R, Levy-Lahad E, Horowitz M, Zimran A (1993) Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy. Q J Med 86:565–573PubMed

17.

Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E (1989) Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet 2:349–352PubMedCrossRef

Title: A disease severity scoring system for children with type 1 Gaucher disease
Authors: Staci Kallish
Paige Kaplan
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: European Journal of Pediatrics / Issue 1/2013
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-012-1830-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A disease severity scoring system for children with type 1 Gaucher disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis

Don’t forget to report “simple” finding on CT: the hypodense eye lens

Simultaneous EMG–fMRI during startle inhibition in monosymptomatic enuresis—an exploratory study

The controversy regarding the need for hormonal treatment in boys with unilateral cryptorchidism goes on: a review of the literature

Atlantooccipital septic arthritis complicating recurrent otitis media

Association of adipokines with cardiovascular risk factors in low birth weight children: a case–control study